OncoResponse, Inc.
4Patents
4Active
4Granted
43Portfolio score
Filing activity: Jul 17, 2020 → Mar 17, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11034770B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11634501B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11827715B2 | Human CD163 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12195549B2 | Immunomodulatory antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.